These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 74379)

  • 21. Prekallikrein activation and kallikrein inactivation in human plasma.
    van der Graaf F; Keus JF; Koedam JA; Rietveld A; Bouma BN
    Adv Exp Med Biol; 1983; 156():143-8. PubMed ID: 6190365
    [No Abstract]   [Full Text] [Related]  

  • 22. Computerized immunoblot analyses (CIBA) of the distribution of prekallikrein and its activation products in vivo and in vitro.
    Veloso D; Campbell G
    Agents Actions Suppl; 1992; 38 ( Pt 1)():166-73. PubMed ID: 1281607
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Behaviour of the contact phase of blood coagulation in the adult respiratory distress syndrome (ARDS).
    Velasco F; Torres A; Guerrero A; Andres P; Guerrero R; Aljama P; Alvarez F
    Thromb Haemost; 1986 Jun; 55(3):357-60. PubMed ID: 2428125
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complement, Kinins, and Hereditary Angioedema: Mechanisms of Plasma Instability when C1 Inhibitor is Absent.
    Kaplan AP; Joseph K
    Clin Rev Allergy Immunol; 2016 Oct; 51(2):207-15. PubMed ID: 27273087
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simple chromogenic peptide substrate assays for determining prekallikrein, kallikrein inhibition and kallikrein "like" activity in human plasma.
    Gallimore MJ; Friberger P
    Thromb Res; 1982 Feb; 25(3):293-8. PubMed ID: 6917564
    [No Abstract]   [Full Text] [Related]  

  • 26. Activation of the kallikrein-kinin system after endotoxin administration to normal human volunteers.
    DeLa Cadena RA; Suffredini AF; Page JD; Pixley RA; Kaufman N; Parrillo JE; Colman RW
    Blood; 1993 Jun; 81(12):3313-7. PubMed ID: 7685203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of vascular permeability by antisense-mediated inhibition of plasma kallikrein and coagulation factor 12.
    Bhattacharjee G; Revenko AS; Crosby JR; May C; Gao D; Zhao C; Monia BP; MacLeod AR
    Nucleic Acid Ther; 2013 Jun; 23(3):175-87. PubMed ID: 23582057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Binding of a monoclonal anti-human plasma prekallikrein antibody to the complexes of kallikrein with C1-inhibitor and alpha 2-macroglobulin analyzed by immunoblot and "sandwich" assays.
    Veloso D; Tseng SY; Craig AR; Colman RW
    Adv Exp Med Biol; 1989; 247A():499-505. PubMed ID: 2481391
    [No Abstract]   [Full Text] [Related]  

  • 29. Prorenin-renin conversion by the contact activation system in human plasma: role of plasma protease inhibitors.
    Derkx FH; Bouma BN; Schalekamp MA
    J Lab Clin Med; 1984 Apr; 103(4):560-73. PubMed ID: 6366096
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The contact activation system: biochemistry and interactions of these surface-mediated defense reactions.
    Colman RW; Schmaier AH
    Crit Rev Oncol Hematol; 1986; 5(1):57-85. PubMed ID: 3633772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protection of human plasma kallikrein from inactivation by C1 inhibitor and other protease inhibitors. The role of high molecular weight kininogen.
    Schapira M; Scott CF; Colman RW
    Biochemistry; 1981 May; 20(10):2738-43. PubMed ID: 6910423
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kinin activation as a predictive assay for adverse reactions to radiographic contrast medium.
    Carr DH; Walker AC
    Acta Radiol Diagn (Stockh); 1984; 25(4):337-42. PubMed ID: 6567445
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New and rapid functional assay for C1 inhibitor in human plasma.
    Schapira M; Silver LD; Scott CF; Colman RW
    Blood; 1982 Apr; 59(4):719-24. PubMed ID: 6174161
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation and inhibition of Hageman factor-dependent pathways and the complement system in uncomplicated bacteremia or bacterial shock.
    Kalter ES; Daha MR; ten Cate JW; Verhoef J; Bouma BN
    J Infect Dis; 1985 Jun; 151(6):1019-27. PubMed ID: 2582065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decrease of plasma prekallikrein and kallikrein inhibitors during intravenous phlebography.
    Aronen HJ; Torstila I; Vahtera E; Suoranta HT
    Eur J Radiol; 1988 Feb; 8(1):30-3. PubMed ID: 2451609
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A study of the plasma kinin-generating system in children with the minimal lesion, idiopathic nephrotic syndrome.
    Kallen RJ; Lee SK
    Pediatr Res; 1975 Sep; 9(9):705-9. PubMed ID: 53808
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of cold activation of the contact system in hereditary angioedema with normal C1 inhibitor.
    Larrauri B; Hester CG; Jiang H; Miletic VD; Malbran A; Bork K; Kaplan A; Frank M
    Mol Immunol; 2021 Aug; 136():150-160. PubMed ID: 34153620
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Plasma kallikrein-kinin system in hypercoagulable state (author's transl)].
    Koie K; Kamiya T; Takamatsu J; Hayashi K; Saito H
    Rinsho Ketsueki; 1980 Jun; 21(6):704-13. PubMed ID: 6450843
    [No Abstract]   [Full Text] [Related]  

  • 39. Activation mechanism of human Hageman factor-plasma kallikrein-kinin system by Vibrio vulnificus metalloprotease.
    Miyoshi S; Shinoda S
    FEBS Lett; 1992 Aug; 308(3):315-9. PubMed ID: 1380471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma prekallikrein, factor XII, antithrombin III, C1(-)-inhibitor and alpha 2-macroglobulin in critically ill patients with suspected disseminated intravascular coagulation (DIC).
    Lämmle B; Tran TH; Ritz R; Duckert F
    Am J Clin Pathol; 1984 Oct; 82(4):396-404. PubMed ID: 6206713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.